Difficulty: Medium
Average Score: 79%
Practice
Which of the following drugs is correctly associated with its clinical application?
Correct answer
D
Rationale
The correct answer is D) Ferrous sulfate: Microcytic anemia of pregnancy. Ferrous sulfate is a form of iron supplement commonly used to treat microcytic anemia, which is characterized by small red blood cells. During pregnancy, the demand for iron increases to support the growing fetus and the mother's own increased blood volume, making iron supplementation crucial in preventing and treating anemia.
Option A) Erythropoietin: Macrocytic anemia is incorrect because erythropoietin is a hormone that stimulates red blood cell production and is used to treat anemia associated with chronic kidney disease or chemotherapy, which often presents as normocytic or microcytic anemia.
Option B) Filgrastim: Thrombocytopenia due to myelocytic leukemia is incorrect because filgrastim is a medication that stimulates the production of white blood cells, specifically neutrophils, and is used to reduce the risk of infection in patients undergoing chemotherapy. It is not indicated for thrombocytopenia or in the context of myelocytic leukemia.
Option C) Iron dextran: Severe macrocytic anemia is incorrect because iron dextran is also an iron supplement like ferrous sulfate but is typically used for severe iron deficiency anemia rather than macrocytic anemia, which may be due to other underlying causes such as vitamin B12 deficiency.
Understanding the correct drug associations with specific clinical conditions is crucial for healthcare professionals to make informed decisions when prescribing medications. In this case, knowing that ferrous sulfate is indicated for microcytic anemia of pregnancy highlights the importance of tailored treatment approaches based on the underlying etiology of anemia.
Option A) Erythropoietin: Macrocytic anemia is incorrect because erythropoietin is a hormone that stimulates red blood cell production and is used to treat anemia associated with chronic kidney disease or chemotherapy, which often presents as normocytic or microcytic anemia.
Option B) Filgrastim: Thrombocytopenia due to myelocytic leukemia is incorrect because filgrastim is a medication that stimulates the production of white blood cells, specifically neutrophils, and is used to reduce the risk of infection in patients undergoing chemotherapy. It is not indicated for thrombocytopenia or in the context of myelocytic leukemia.
Option C) Iron dextran: Severe macrocytic anemia is incorrect because iron dextran is also an iron supplement like ferrous sulfate but is typically used for severe iron deficiency anemia rather than macrocytic anemia, which may be due to other underlying causes such as vitamin B12 deficiency.
Understanding the correct drug associations with specific clinical conditions is crucial for healthcare professionals to make informed decisions when prescribing medications. In this case, knowing that ferrous sulfate is indicated for microcytic anemia of pregnancy highlights the importance of tailored treatment approaches based on the underlying etiology of anemia.